Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Public ClinicalTrials.gov record NCT05556824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Study of Panosyl-Isomaltooligosaccharides (PIMO) Adjunctive to Proton Pump Inhibitor (PPI) Therapy to Treat Gastroesophageal Reflux Disease (GERD) in Subjects Who Are PPI-Responders or PPI-Partial Responders
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effect of MHS-1031 on heartburn-free days in subjects with GERD-related heartburn symptoms.
Study identification
- NCT ID
- NCT05556824
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2023
- Primary completion
- May 26, 2026
- Completion
- May 26, 2026
- Last update posted
- Jul 26, 2026
2023 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Elite Clinical Studies LLC | Phoenix | Arizona | 85018 | — |
| Angel City Research | Los Angeles | California | 90010 | — |
| Wr-Msra, Llc | Lake City | Florida | 32055 | — |
| A Positive Clinical Research | Miami | Florida | 33186 | — |
| Advanced Gastroenterology Associates LLC | Palm Harbor | Florida | 34684 | — |
| Health Synergy Clinical Research | West Palm Beach | Florida | 33407 | — |
| West Palm Quality Research (WPQR) | West Palm Beach | Florida | 33407 | — |
| EmVenio-Georgia (EMGA) | Atlanta | Georgia | 30345 | — |
| WR-Mount Vernon Clinical Research (MVCR) | Sandy Springs | Georgia | 30328 | — |
| Gastroenterology Associates of Western Michigan PLC (WMCR) | Wyoming | Michigan | 49519 | — |
| M3 Wake Research (CPOR) | Raleigh | North Carolina | 27612 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| SMS Clinical Research (SMSR) | Mesquite | Texas | 75149 | — |
| A and U Family Medicine (NCR) | Sugar Land | Texas | 77479 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| Charlottesville Medical Research Center | Charlottesville | Virginia | 22911 | — |
| Digestive Disease and Liver Specialists | Norfolk | Virginia | 23502 | — |
| GI Research Partners, LLC | Richmond | Virginia | 23236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05556824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05556824 live on ClinicalTrials.gov.